Skip to content
411 PRESS
CriticalRecall #D-0397-2026Drug / Pharmaceutical

StuffbyNainax Recalls MR

StuffbyNainax · Class I — Most Serious

Assorted pharmaceutical pills and tablets — representative photo for FDA drug recall
An assortment of pharmaceutical pills (representative file photo). Specific recalled product: see recall details below. Photo: Michael Nutt / Wikimedia Commons (CC BY-SA 2.0).

Product Description

MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7

Reason for Recall

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil

FDA Classification

Class I — Most Serious

A situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.

Distribution

Product was distributed to 4 customers in the US.

Remedy

Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.

411 Press Analysis

The FDA has classified this as a Class I recall — the most serious classification reserved for situations where there is a reasonable probability that use of, or exposure to, the product will cause serious adverse health consequences or death. StuffbyNainax initiated this recall of pharmaceutical product on December 15, 2025 affecting 4. Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil. The product was distributed nationwide. Consumers who have this product should stop using it immediately and contact the recalling firm.

Independent news on labor, safety, and accountability.